Through such close proximity of this SNP to the MSMB gene and the recorded variation, findings are consistent with the observation that an allele variant found in the 23andMe analysis could potentially have an effect on the promoter region of MSMB, suggesting a causal variant at 10q11 that confers increased risk of prostate cancer. The gene discussed is MSMB; the disease is prostate cancer.